• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罕见的起源于沃尔夫管的女性附件恶性肿瘤(FATWO)伴多次复发及化疗方案

RARE MALIGNANT FEMALE ADNEXAL TUMOR OF WOLFFIAN ORIGIN (FATWO) WITH MULTIPLE RELAPSES AND CHEMOTHERAPY REGIMENS.

作者信息

Piciu A, Cainap C, Sur D, Havasi A, Fetica B, Balacescu O, Mester A, Cainap S

机构信息

"Iuliu Hatieganu" University of Medicine and Pharmacy, Faculty of Medicine - Medical Oncology, Cluj-Napoca, Romania.

"Prof Dr Ion Chiricuta" Oncology Institute - Pathology and Molecular Biology, Cluj-Napoca, Romania.

出版信息

Acta Endocrinol (Buchar). 2021 Apr-Jun;17(2):259-265. doi: 10.4183/aeb.2021.259.

DOI:10.4183/aeb.2021.259
PMID:34925577
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8665256/
Abstract

CONTEXT

Female adnexal tumors of probable Wolffian origin (FATWO) represent very rare borderline ovarian tumors with low malignant potential. Only 15 cases of malignant FATWO are described in the current literature, among which, only 5 are reported as being recurrent.

OBJECTIVE

Due to the rare presentation of the recurrence of the malignant FATWO and the few cases reported in the scientific database, there are no clear therapy recommendations. This paper should help practitioners to choose the best therapy approach.

DESIGN

This paper presents the 6 case of malignant recurrent FATWO and will compare all the cases available in the literature.

SUBJECTS AND METHODS

We present a review of the literature comparing the therapeutic approaches and outcomes of all the five cases of recurrent malignant FATWOs. Also, we introduce the case of a stage III Wolffian origin adnexal tumor with multiple recurrences appeared after 6 years of disease free interval.

RESULTS

Our case presents the longest survival reported in the literature and underwent most surgical procedures of the recurrences and more than 4 lines of chemotherapy regimens.

CONCLUSIONS

This paper shows possible therapeutic approaches to be used as example by the practitioners according to the drug availability in their centers.

摘要

背景

可能起源于沃尔夫管的女性附件肿瘤(FATWO)是非常罕见的低恶性潜能的交界性卵巢肿瘤。目前文献中仅描述了15例恶性FATWO,其中仅有5例报告有复发情况。

目的

由于恶性FATWO复发情况罕见且科学数据库中报告的病例较少,目前尚无明确的治疗建议。本文旨在帮助从业者选择最佳治疗方法。

设计

本文介绍了6例复发性恶性FATWO病例,并将对文献中所有可用病例进行比较。

研究对象与方法

我们对文献进行综述,比较所有5例复发性恶性FATWO的治疗方法和结果。此外,我们还介绍了1例III期起源于沃尔夫管的附件肿瘤病例,该病例在无病间隔6年后出现多次复发。

结果

我们的病例是文献中报道生存时间最长的,经历了最多的复发手术和超过4线的化疗方案。

结论

本文展示了一些可能的治疗方法,从业者可根据其所在中心的药物供应情况将其作为范例使用。

相似文献

1
RARE MALIGNANT FEMALE ADNEXAL TUMOR OF WOLFFIAN ORIGIN (FATWO) WITH MULTIPLE RELAPSES AND CHEMOTHERAPY REGIMENS.罕见的起源于沃尔夫管的女性附件恶性肿瘤(FATWO)伴多次复发及化疗方案
Acta Endocrinol (Buchar). 2021 Apr-Jun;17(2):259-265. doi: 10.4183/aeb.2021.259.
2
Recurrent and metastatic female adnexal tumor of probable Wolffian origin: A case report and review of the literature.可能源自 Wolffian 起源的复发性和转移性女性附件肿瘤:病例报告及文献复习。
Medicine (Baltimore). 2021 Apr 2;100(13):e25377. doi: 10.1097/MD.0000000000025377.
3
Diagnosis and management of female adnexal tumor of probable Wolffian origin (FATWO) arising from ovary: a case report.卵巢来源的可能为中肾管起源的女性附件肿瘤(FATWO)的诊断与处理:一例报告
J Turk Ger Gynecol Assoc. 2013 Mar 1;14(1):56-9. doi: 10.5152/jtgga.2013.14. eCollection 2013.
4
Everolimus plus anastrozole for female adnexal tumor of probable Wolffian origin (FATWO) with mutation.依维莫司联合阿那曲唑治疗伴有特定突变的可能源自中肾管的女性附件肿瘤(FATWO)。
Gynecol Oncol Rep. 2021 Jul 23;37:100838. doi: 10.1016/j.gore.2021.100838. eCollection 2021 Aug.
5
Recurrent female adnexal tumor of probable Wolffian origin treated with debulking surgery, imatinib and paclitaxel/carboplatin combination chemotherapy: A case report.采用减瘤手术、伊马替尼及紫杉醇/卡铂联合化疗治疗的可能起源于中肾管的复发性女性附件肿瘤:病例报告
Oncol Lett. 2017 May;13(5):3403-3408. doi: 10.3892/ol.2017.5874. Epub 2017 Mar 17.
6
Female Adnexal Tumour of Probable Wolffian Origin (FATWO): Review of the Literature.可能起源于沃尔夫管的女性附件肿瘤(FATWO):文献综述
Geburtshilfe Frauenheilkd. 2019 Mar;79(3):281-285. doi: 10.1055/a-0746-8985. Epub 2019 Mar 12.
7
Female Adnexal Tumor of Probable Wolffian Origin: A Review.可能来源于 Wolffian 组织的女性附件肿瘤:综述。
Arch Pathol Lab Med. 2020 Jan;144(1):24-28. doi: 10.5858/arpa.2019-0152-RA. Epub 2019 Aug 30.
8
Targeted Genomic Profiling of Female Adnexal Tumors of Probable Wolffian Origin (FATWO).可能来源于 Wolffian 组织的女性附件肿瘤的靶向基因组分析(FATWO)。
Int J Gynecol Pathol. 2019 Nov;38(6):543-551. doi: 10.1097/PGP.0000000000000545.
9
Malignant Female Adnexal Tumor of Probable Wolffian Origin (FATWO): A case report and review for the literature.可能起源于沃尔夫管的恶性女性附件肿瘤(FATWO):一例病例报告及文献复习
Gynecol Oncol Rep. 2021 Feb 9;36:100726. doi: 10.1016/j.gore.2021.100726. eCollection 2021 May.
10
Female adnexal tumor of probable wolffian origin: morphological, immunohistochemical, and ultrastructural study with c-kit gene analysis.可能起源于中肾管的女性附件肿瘤:形态学、免疫组织化学及超微结构研究与c-kit基因分析
Pathol Int. 2006 Feb;56(2):95-100. doi: 10.1111/j.1440-1827.2006.01930.x.

引用本文的文献

1
Malignant Wolffian adnexal tumor in the ovary: a case report and literature review.卵巢恶性中肾旁管附属器肿瘤:1例报告及文献复习
Front Oncol. 2025 Mar 18;15:1526030. doi: 10.3389/fonc.2025.1526030. eCollection 2025.
2
SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors: Nonepithelial Ovarian Cancer.SWOG/NCI 二期临床试验:在罕见肿瘤(非上皮性卵巢癌)中双重抗CTLA-4/PD-1阻断疗法
Clin Cancer Res. 2024 Dec 16;30(24):5593-5600. doi: 10.1158/1078-0432.CCR-24-0606.
3
Fertility options after chemotherapy in young premenopausal patients.年轻绝经前患者化疗后的生育选择。
Acta Endocrinol (Buchar). 2023 Jul-Sep;19(3):398-402. doi: 10.4183/aeb.2023.398. Epub 2024 Feb 1.
4
Rare giant female adnexal tumor of probable Wolffian origin: a case report.罕见的可能起源于沃尔夫管的巨大女性附件肿瘤:病例报告
J Surg Case Rep. 2022 May 27;2022(5):rjac243. doi: 10.1093/jscr/rjac243. eCollection 2022 May.

本文引用的文献

1
Nintedanib for Advanced Epithelial Ovarian Cancer: A Change of Perspective? Summary of Evidence from a Systematic Review.尼达尼布用于晚期上皮性卵巢癌:视角转变?一项系统评价的证据总结
Gynecol Obstet Invest. 2019;84(2):107-117. doi: 10.1159/000493361. Epub 2018 Oct 10.
2
Female adnexal tumor of probable Wolffian origin arising from mesosalpinx: A case report and review.起源于输卵管系膜的可能为中肾管来源的女性附件肿瘤:一例报告及文献复习
J Obstet Gynaecol Res. 2018 Sep;44(9):1859-1863. doi: 10.1111/jog.13704. Epub 2018 Jul 5.
3
The Importance of Fertility Preservation Counseling in Patients with Gynecologic Cancer.妇科癌症患者生育力保护咨询的重要性。
J Reprod Infertil. 2017 Apr-Jun;18(2):261-263.
4
Fertility Sparing Strategies in Patients Affected by Placental Site Trophoblastic Tumor.胎盘部位滋养细胞肿瘤患者的保留生育功能策略。
Curr Treat Options Oncol. 2017 Aug 24;18(10):58. doi: 10.1007/s11864-017-0502-0.
5
Recurrent female adnexal tumor of probably Wolffian origin: A case report.复发性可能起源于 Wolff 管的女性附件肿瘤:一例报告。
Taiwan J Obstet Gynecol. 2017 Jun;56(3):382-384. doi: 10.1016/j.tjog.2016.12.017.
6
Recurrent female adnexal tumor of probable Wolffian origin treated with debulking surgery, imatinib and paclitaxel/carboplatin combination chemotherapy: A case report.采用减瘤手术、伊马替尼及紫杉醇/卡铂联合化疗治疗的可能起源于中肾管的复发性女性附件肿瘤:病例报告
Oncol Lett. 2017 May;13(5):3403-3408. doi: 10.3892/ol.2017.5874. Epub 2017 Mar 17.
7
Female Adnexal Tumors of Probable Wolffian Origin (FATWO): A Case Series With Next-Generation Sequencing Mutation Analysis.可能起源于中肾管的女性附件肿瘤(FATWO):一项采用二代测序突变分析的病例系列研究
Int J Gynecol Pathol. 2017 Nov;36(6):575-581. doi: 10.1097/PGP.0000000000000368.
8
Fertility sparing surgery for stage IA type I and G2 endometrial cancer in reproductive-aged patients: evidence-based approach and future perspectives.生育期患者IA期I型和G2级子宫内膜癌的保留生育功能手术:循证方法与未来展望
Updates Surg. 2017 Mar;69(1):29-34. doi: 10.1007/s13304-017-0419-y. Epub 2017 Feb 10.
9
Epithelial ovarian cancer inherent resistance: May the pleiotropic interaction between reduced immunosurveillance and drug-resistant cells play a key role?上皮性卵巢癌固有耐药性:免疫监视降低与耐药细胞之间的多效性相互作用可能起关键作用?
Gynecol Oncol Rep. 2016 Sep 19;18:57-58. doi: 10.1016/j.gore.2016.09.004. eCollection 2016 Nov.
10
Cytogenetic analysis of epithelial ovarian cancer's stem cells: an overview on new diagnostic and therapeutic perspectives.上皮性卵巢癌干细胞的细胞遗传学分析:新诊断与治疗前景概述
Eur J Gynaecol Oncol. 2015;36(5):495-505.